The Oklahoma Medical Research Foundation today announced receipt of patents on an in vitro process for inactivation of the Human Immunodeficiency Virus (HIV) in blood used for transfusions. Available blood testing for HIV and other blood-borne virus antibodies may not reveal presence of the virus for as much as seven to ten days after the infection […]
News
- « Go to Previous Page
- Page 1
- Interim pages omitted …
- Page 264
- Page 265
- Page 266
